MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: Strategic Corporate Investment & Corporate Venture Capital (CVC)
*Portfolio Companies: Eli Lilly
Cerulean Pharmaceuticals
Organization & Developments: Cerulean
Parents
Cerulean Pharmaceuticals
Children
2015: The Near Death, and Second Life, of Cerulean Pharma
2016: Cerulean inks collaboration with Novartis and nabs $20M equity investment at $1.25; shares up 78% premarket - Cerulean Pharma Inc. (NASDAQ:CERU)
Cerulean’s Dynamic Tumor Targeting™ Platform creates nanoparticle-drug conjugates (NDCs)
Leader in designing and developing nanopharmaceuticals
The deal gives the startup funding for a mid-stage clinical trial of its lead nanoparticle drug, CRLX101, for patients with lung cancer.
Jumps
*Key People: Cerulean
Finance & Acquisition: Cerulean